Atai Life Sciences N.V. (ATAI) — SC 13D/A Filings
All SC 13D/A filings from Atai Life Sciences N.V.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
ATAI Life Sciences AG Amends COMPASS Pathways Stake Filing
— Sep 27, 2024 Risk: medium
ATAI Life Sciences AG, through its subsidiary ATAI Life Sciences N.V., has filed an amendment (Amendment No. 3) to its Schedule 13D concerning its holdings in C -
ATAI Life Sciences Files SC 13D/A Amendment
— May 3, 2024 Risk: medium
On May 3, 2024, ATAI Life Sciences N.V. filed an amendment (Amendment No. 3) to its Schedule 13D regarding its holdings in IntelGenx Technologies Corp. The fili -
ATAI Life Sciences Files 13D/A Amendment
— Mar 12, 2024 Risk: medium
ATAI Life Sciences N.V. filed an amendment (No. 2) to its Schedule 13D on March 12, 2024, regarding its beneficial ownership of IntelGenx Technologies Corp. ATA
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX